Ponatinib pharmacy drug
Ended Awarded Last action
- Contract number
- 36C26018N1194
- Awardee
-
Ariad Pharmaceuticals, Inc. UEI EVMMLCKBZS47 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $92,018
Award facts
- Contract value 100% obligated
- $92,017.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$23,004 | |
| Original award | $115,022 |
About this award
This is a firm fixed-price contract awarded by the Veterans Integrated Service Network 20 (VISN 20) of the Department of Veterans Affairs (VA) to Ariad Pharmaceuticals, Inc., a subsidiary of Takeda Pharmaceutical Company LIMITED. The contract, valued at $92,017.60, is for the delivery of the oncology drug Ponatinib under the GSA Pharmaceuticals and Drugs schedule. This contract was not set aside and is part of the VA's efforts to provide critical cancer medications to veterans through its healthcare system. Ariad Pharmaceuticals, a global pharmaceutical company, has previously received other federal contract awards from the VA to supply oncology drugs such as Iclusig and Lenvima. The parent company, Takeda Pharmaceutical, is an active participant in federal contracting, providing a range of pharmaceutical products and medical research solutions to various government agencies.
Quick answers
Who was awarded contract 36C26018N1194?
36C26018N1194 was awarded to Ariad Pharmaceuticals, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on August 13, 2018.
How much is contract 36C26018N1194 worth?
The government has obligated $92,018 on 36C26018N1194.
Is contract 36C26018N1194 an order under another contract?
Yes. 36C26018N1194 is a BPA call under V797D50395-VA797P15A0016, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26018N1194 competed?
The extent of competition for 36C26018N1194 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award